Friday, 24 April 2026 — Publication BB Biotech Interim Report Q1 2026 To the report
Friday, 24 April 2026 — Publication BB Biotech Interim Report Q1 2026 To the report
Discover how we identify and capitalize on biotech innovation.
Read the storyBreakthrough innovation, structural growth and global demand are reshaping healthcare and creating long-term value opportunities for investors.
ViewWe aim to turn scientific innovation into sustainable value through disciplined investing and deep biotech expertise.
ViewA multidisciplinary team combining scientific knowledge and investment experience to make high-conviction decisions.
ViewBB BIOTECH AG | BION
Closing prices as of 30 Apr 2026
An overview of market dynamics, capital flows, and innovation trends shaping long-term biotech returns.
Read the storySee portfolio structure, key exposures, and concentration at a glance.
ViewExplore current holdings, focus areas, and the science driving each investment.
ViewA disciplined process combining research depth, risk control, and long-term perspective.
ViewOur most recent financial report, including performance, portfolio developments, and key highlights.
DownloadDetailed financial statements, notes, and disclosures providing full transparency on results and financial position.
ViewMonthly snapshots of key figures, portfolio composition, and performance metrics.
ViewAccess to historical reports, factsheets, and financial documents from previous periods.
ViewArticles, videos, and conversations exploring biotech, markets, and our investment thinking.
ViewOfficial company announcements and regulatory communications.
ViewPrice-sensitive disclosures published in line with regulatory requirements.
ViewDirect contact details for media and press enquiries.
ViewDiscover how we identify and capitalize on biotech innovation.
Read the storyBreakthrough innovation, structural growth and global demand are reshaping healthcare and creating long-term value opportunities for investors.
ViewWe aim to turn scientific innovation into sustainable value through disciplined investing and deep biotech expertise.
ViewA multidisciplinary team combining scientific knowledge and investment experience to make high-conviction decisions.
View
BB BIOTECH AG | BION
Closing prices as of 30 Apr 2026
An overview of market dynamics, capital flows, and innovation trends shaping long-term biotech returns.
Read the storySee portfolio structure, key exposures, and concentration at a glance.
ViewExplore current holdings, focus areas, and the science driving each investment.
ViewA disciplined process combining research depth, risk control, and long-term perspective.
ViewOur most recent financial report, including performance, portfolio developments, and key highlights.
DownloadDetailed financial statements, notes, and disclosures providing full transparency on results and financial position.
ViewMonthly snapshots of key figures, portfolio composition, and performance metrics.
ViewAccess to historical reports, factsheets, and financial documents from previous periods.
ViewArticles, videos, and conversations exploring biotech, markets, and our investment thinking.
ViewOfficial company announcements and regulatory communications.
ViewPrice-sensitive disclosures published in line with regulatory requirements.
ViewDirect contact details for media and press enquiries.
ViewUpdate your browser to view this website correctly.
Thank you for your interest in BB Biotech. Unfortunately, this page cannot be displayed due to the information you have entered in the disclaimer (country of domicile / investor type). www.bbbiotech.ch
